Regulators inspect manufacturers, not software vendors. When an FDA investigator, an MHRA inspector or a CDSCO team reviews your computerised systems, they ask how you validated the system for its intended use, how you control access, how you review audit trails and how your people are trained. A vendor that calls its product “fully compliant” or “validated” is claiming something it cannot deliver on your behalf.
So we describe Swat iQua Suite precisely. It is designed to comply with the regulations listed on these pages: the technical controls those regulations expect — audit trails, electronic signatures, access control, segregation of duties, trusted time, controlled records — are built into the platform and enforced on the server. Every module inherits them, so a new module arrives with the same controls as the rest.
What you can rely on the platform for
- Every write and its audit-trail entry commit together, with old and new values, the user, the time and a mandatory reason for the change.
- Electronic signatures that re-authenticate the signer, configured per module and per site, with the signer’s name, designation and meaning recorded.
- Segregation of duties enforced on the server — the preparer cannot review, the reviewer cannot approve, and the person who ran the batch cannot release it.
- Approved masters that are versioned, so every downstream record knows which specification, formula or SOP version applied.
- Release decisions that are blocked while critical evidence is missing, and inspection evidence packages sealed with a checksum manifest.
What stays with you
Validation of your installation for its intended use, your SOPs for using and administering the system, user training, periodic review of audit trails and access, and the decisions your quality unit takes. We support your validation with requirements traceability in the CSA register, evidence of the Part 11 controls and our team working alongside your QA and CSV leads — but the validated state belongs to your organisation, for your installation.
One evidence trail for every market — FDA, MHRA, EMA, CDSCO and WHO inspections from the same records.
